These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25183399)

  • 41. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.
    Park IH; Li C
    J Mol Recognit; 2011; 24(2):254-65. PubMed ID: 21360612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
    Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
    Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?
    Schröder M; Kroeger KM; Volk HD; Eidne KA; Grütz G
    J Leukoc Biol; 2004 May; 75(5):792-7. PubMed ID: 14742639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
    Xia Z; Baer MR; Block AW; Baumann H; Wetzler M
    Cancer Res; 1998 Jul; 58(14):3173-80. PubMed ID: 9679986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation.
    Nelson EA; Sharma SV; Settleman J; Frank DA
    Oncotarget; 2011 Jun; 2(6):518-24. PubMed ID: 21680956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules.
    Kang K; Robinson GW; Hennighausen L
    BMC Genomics; 2013 Jan; 14():4. PubMed ID: 23324445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paradigm shifts in the cell biology of STAT signaling.
    Sehgal PB
    Semin Cell Dev Biol; 2008 Aug; 19(4):329-40. PubMed ID: 18691663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics.
    Karamouzis MV; Konstantinopoulos PA; Papavassiliou AG
    J Mol Med (Berl); 2007 May; 85(5):427-36. PubMed ID: 17216202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic modulators of STAT signalling for human diseases.
    Miklossy G; Hilliard TS; Turkson J
    Nat Rev Drug Discov; 2013 Aug; 12(8):611-29. PubMed ID: 23903221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.
    Hato SV; Figdor CG; Takahashi S; Pen AE; Halilovic A; Bol KF; Vasaturo A; Inoue Y; de Haas N; Verweij D; Van Herpen CML; Kaanders JH; van Krieken JHJM; Van Laarhoven HWM; Hooijer GKJ; Punt CJA; Asai A; de Vries IJM; Lesterhuis WJ
    Oncotarget; 2017 Aug; 8(33):54434-54443. PubMed ID: 28903353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoparticles Targeting STATs in Cancer Therapy.
    Ashrafizadeh M; Ahmadi Z; Kotla NG; Afshar EG; Samarghandian S; Mandegary A; Pardakhty A; Mohammadinejad R; Sethi G
    Cells; 2019 Sep; 8(10):. PubMed ID: 31569687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targets.
    Walker SR; Frank DA
    JAKSTAT; 2012 Oct; 1(4):292-9. PubMed ID: 24058786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain.
    Hua Y; Yuan X; Shen YH; Wang J; Azeem W; Yang S; Gade A; Lellahi SM; Øyan AM; Ke X; Zhang WD; Kalland KH
    Front Pharmacol; 2022; 13():836724. PubMed ID: 35712699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STAT module can function as a biphasic amplitude filter.
    Mayya V; Loew LM
    Syst Biol (Stevenage); 2005 Mar; 2(1):43-52. PubMed ID: 17091582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.
    Arshad S; Naveed M; Ullia M; Javed K; Butt A; Khawar M; Amjad F
    Genet Mol Biol; 2020; 43(1):e20180160. PubMed ID: 32167126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation.
    Timofeeva OA; Tarasova NI
    JAKSTAT; 2012 Oct; 1(4):274-84. PubMed ID: 24058784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.
    Tweardy DJ
    Trans Am Clin Climatol Assoc; 2022; 132():61-76. PubMed ID: 36196170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications.
    Plens-Gałąska M; Woźniak T; Wesoły J; Bluyssen HAR
    Sci Data; 2022 Mar; 9(1):139. PubMed ID: 35361787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a "non-druggable" target, STAT3 N-terminal domain.
    Bonilla PA; Hoop CL; Stefanisko K; Tarasov SG; Sinha S; Nicklaus MC; Tarasova NI
    Front Oncol; 2023; 13():1144153. PubMed ID: 37182134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of new
    Urlam MK; Pireddu R; Ge Y; Zhang X; Sun Y; Lawrence HR; Guida WC; Sebti SM; Lawrence NJ
    Medchemcomm; 2013 Jun; 4(6):932-941. PubMed ID: 24073326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.